Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials - Patoulias, Dimitrios; Popovic, Djordje S.; Stoian, Anca Pantea; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, Manfredi (Journal of diabetes and its complications, 2023)
Keywords: Antidiabetics; Atherosclerosis; Bias; Blood pressure; Cholesterol; Clinical trials; Diabetes; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide-1 receptor agonist; Glucagon-Like Peptide-1 Receptor Agonists; Glycated Hemoglobin; Glycemia; Humans; Hypoglycemic Agents - adverse effects; Meta-analysis; Metabolism; Peptides; Randomized Controlled Trials as Topic; Risk factor; Risk Factors; Semaglutide; Systematic review; Type 2 diabetes; Type 2 diabetes; Semaglutide; Glucagon-like peptide-1 receptor agonist; Glycemia; Risk factor